Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (121-130 of 242) with videos related to

Pageof 25
Sort By:
Nature Communications|September 13, 2023
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s diseaseMarta Del Campo, Lisa Vermunt, Carel F W Peeters, et al.
JAMA Network Open|May 23, 2022
Association of Alzheimer Disease With Life Expectancy in People With Down SyndromeMaria Florencia Iulita, Diana Garzón Chavez, Maria Klitgaard Christensen, et al.
Alzheimer'S Research & Therapy|July 22, 2025
CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patientsMarlies Oosthoek, Everard G B Vijverberg, Elena R Blujdea, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 5, 2015
Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunamiEva Martínez-Lizana, María Carmona-Iragui, Daniel Alcolea, et al.
Brain : a Journal of Neurology|March 26, 2019
Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophyIgnacio Illán-Gala, Victor Montal, Sergi Borrego-Écija, et al.
Alzheimer'S Research & Therapy|February 2, 2022
The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 aloneConstance Delaby, Teresa Estellés, Nuole Zhu, et al.
Neurology|September 11, 2020
Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuumIgnacio Illán-Gala, Victor Montal, Jordi Pegueroles, et al.
International Journal of Molecular Sciences|July 9, 2022
Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona CohortAdelina Orellana, Pablo García-González, Sergi Valero, et al.
Nature Neuroscience|July 17, 2019
Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer's disease pathogenesisPilar Esteve, Javier Rueda-Carrasco, María Inés Mateo, et al.
Neurology|July 17, 2015
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer diseaseDaniel Alcolea, Pablo Martínez-Lage, Pascual Sánchez-Juan, et al.
Pageof 25

Showing results (121-130 of 242) with videos related to

Sort By:
Pageof 25
Nature Communications|September 13, 2023
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s diseaseMarta Del Campo, Lisa Vermunt, Carel F W Peeters, et al.
JAMA Network Open|May 23, 2022
Association of Alzheimer Disease With Life Expectancy in People With Down SyndromeMaria Florencia Iulita, Diana Garzón Chavez, Maria Klitgaard Christensen, et al.
Alzheimer'S Research & Therapy|July 22, 2025
CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patientsMarlies Oosthoek, Everard G B Vijverberg, Elena R Blujdea, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 5, 2015
Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunamiEva Martínez-Lizana, María Carmona-Iragui, Daniel Alcolea, et al.
Brain : a Journal of Neurology|March 26, 2019
Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophyIgnacio Illán-Gala, Victor Montal, Sergi Borrego-Écija, et al.
Alzheimer'S Research & Therapy|February 2, 2022
The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 aloneConstance Delaby, Teresa Estellés, Nuole Zhu, et al.
Neurology|September 11, 2020
Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuumIgnacio Illán-Gala, Victor Montal, Jordi Pegueroles, et al.
International Journal of Molecular Sciences|July 9, 2022
Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona CohortAdelina Orellana, Pablo García-González, Sergi Valero, et al.
Nature Neuroscience|July 17, 2019
Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer's disease pathogenesisPilar Esteve, Javier Rueda-Carrasco, María Inés Mateo, et al.
Neurology|July 17, 2015
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer diseaseDaniel Alcolea, Pablo Martínez-Lage, Pascual Sánchez-Juan, et al.
Pageof 25